IMVT Immunovant, Inc.

Fundamentals / CIK 0001764013 / USD

Immunovant, Inc. reported $761.0M in total assets and a net loss of $509.0M through March 31, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open IMVT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2019 to 2026), reported in USD.

$0$0$0-$472.7MFY 2019 Net Income: -$28.60M2019FY 2020 Net Income: -$66.39M2020FY 2021 Net Income: -$107.4M2021FY 2022 Net Income: -$156.7M2022FY 2023 Net Income: -$211.0M2023FY 2024 Net Income: -$259.3M2024FY 2025 Net Income: -$413.8M2025FY 2026 Net Income: -$505.6M2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Research & Development $456.7M $360.9M $212.9M $160.3M $101.8M $68.60M $47.93M $25.73M
Total Operating Expenses $532.9M $438.2M $282.7M $218.3M $156.0M $108.1M $66.08M $28.43M
Interest Expense -- -- -- -- -- $0 $625K --
Income Before Tax -$505.4M -$412.9M -$258.8M -$211.0M -$156.8M -$107.8M -$66.29M -$28.58M
Income Tax Expense $215K $891K $567K $9.0K -$84K -$358K $97K $19K
Net Income -$505.6M -$413.8M -$259.3M -$211.0M -$156.7M -$107.4M -$66.39M -$28.60M
Basic EPS -$2.77 -$2.73 -$1.88 -$1.71 -$1.43 -$1.22 -$1.54 -$1.29
Diluted EPS -$2.77 -$2.73 -$1.88 -$1.71 -$1.43 -$1.22 -$1.54 -$1.29
Basic Shares Outstanding 182.4M 151.6M 138.1M 123.1M 109.7M 87.8M 43.2M 22.2M
Diluted Shares Outstanding 182.4M 151.6M 138.1M 123.1M 109.7M 87.8M 43.2M 22.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $85.01M $142.6M $142.3M $98.92M $114.2M $101.2M $93.65M $94.52M
Total Operating Expenses $104.2M $160.3M $159.6M $114.4M $131.8M $127.2M $113.8M $114.3M
Income Before Tax -$97.25M -$153.2M -$150.7M -$109.1M -$125.9M -$119.7M -$105.9M -$111.0M
Income Tax Expense $0 $0 -$2.84M $1.55M $594K $913K $583K $152K
Net Income -$97.25M -$153.2M -$147.9M -$110.6M -$126.5M -$120.6M -$106.4M -$111.1M
Basic EPS -$0.47 -$0.75 -- -$0.61 -$0.73 -$0.71 -- -$0.76
Diluted EPS -$0.47 -$0.75 -- -$0.61 -$0.73 -$0.71 -- -$0.76
Basic Shares Outstanding 206.7M 205.5M -- 181.5M 173.6M 170.9M -- 146.9M
Diluted Shares Outstanding 206.7M 205.5M -- 181.5M 173.6M 170.9M -- 146.9M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Cash & Cash Equivalents $902.1M $714.0M $635.4M $376.5M $493.8M $400.1M $100.6M $6.99M
Cash & Short-Term Investments $902.1M $714.0M $635.4M $376.5M $493.8M $400.1M $100.6M $6.99M
Accounts Receivable, Net $1.13M $2.08M $5.34M $700K $12.23M $596K -- --
Total Current Assets $948.8M $767.7M $665.8M $404.3M $512.9M $409.0M $109.1M $12.58M
Property, Plant & Equipment, Net $443K $844K $462K $333K $330K $201K $65K $54K
Other Non-Current Assets $7.75M $7.62M $0 -- -- -- -- --
Total Non-Current Assets $8.20M $8.56M $595K $1.50M $2.63M $3.48M $311K $1.25M
Total Assets $957.0M $776.2M $666.4M $405.8M $515.6M $412.5M $109.4M $13.83M
Accounts Payable $7.54M $17.66M $7.16M $1.35M $18.63M $2.43M $1.19M $206K
Other Current Liabilities $175K $273K $15K $350K -- -- -- --
Total Current Liabilities $104.4M $68.78M $48.61M $43.30M $44.52M $18.77M $15.32M $300K
Total Non-Current Liabilities $0 $0 $0 $47K $1.22M $2.24M $0 $6.19M
Total Liabilities $104.4M $68.78M $48.61M $43.34M $45.74M $21.01M $15.32M $6.49M
Total Debt (incl. Leases) $72K $98K $138K $1.22M $2.36M $3.42M -- --
Common Stock $20K $16K $14K $13K $12K $10K $5.0K $4.0K
Retained Earnings -$1.75B -$1.24B -$825.7M -$566.3M -$355.4M -$198.7M -$91.23M -$24.84M
Accumulated Other Comp. Income $730K $1.46M $1.91M $852K $404K -$298K -$16K $346K
Total Stockholders' Equity $852.6M $707.4M $617.8M $362.5M $469.8M $391.5M $94.07M $7.34M
Total Equity $852.6M $707.4M $617.8M $362.5M $469.8M $391.5M $94.07M $7.34M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $722.3M $797.8M $902.1M $994.5M $521.9M $598.9M $714.0M $374.7M
Cash & Short-Term Investments $722.3M $797.8M $902.1M $994.5M $521.9M $598.9M $714.0M $374.7M
Accounts Receivable, Net $138K $697K $1.13M $1.64M $1.97M $1.94M $2.08M $2.22M
Total Current Assets $760.0M $851.2M $948.8M $1.04B $573.5M $651.8M $767.7M $412.5M
Property, Plant & Equipment, Net $262K $351K $443K $531K $632K $737K $844K $752K
Other Non-Current Assets $659K $961K $7.75M $8.92M $8.78M $8.94M $7.62M $7.62M
Total Non-Current Assets $921K $1.31M $8.20M $9.45M $9.41M $9.68M $8.56M $8.39M
Total Assets $761.0M $852.5M $957.0M $1.05B $583.0M $661.4M $776.2M $420.9M
Accounts Payable $6.79M $10.14M $7.54M $8.62M $6.92M $7.84M $17.66M $19.82M
Other Current Liabilities -- -- $175K -- -- -- $273K --
Total Current Liabilities $104.0M $117.1M $104.4M $66.26M $63.25M $52.90M $68.78M $68.31M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $104.0M $117.1M $104.4M $66.26M $63.25M $52.90M $68.78M $68.31M
Total Debt (incl. Leases) -- -- $72K -- -- -- $98K $23K
Common Stock $20K $20K $20K $20K $17K $16K $16K $14K
Retained Earnings -$2.00B -$1.90B -$1.75B -$1.60B -$1.49B -$1.36B -$1.24B -$1.13B
Accumulated Other Comp. Income $519K $725K $730K $1.20M $1.45M $1.74M $1.46M $2.48M
Total Stockholders' Equity $656.9M $735.4M $852.6M $986.1M $519.7M $608.5M $707.4M $352.6M
Total Equity $656.9M $735.4M $852.6M $986.1M $519.7M $608.5M $707.4M $352.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Net Income -$505.6M -$413.8M -$259.3M -$211.0M -$156.7M -$107.4M -$66.39M -$28.60M
Depreciation & Amortization $409K $377K $231K $193K $126K $65K $21K $10K
Stock-Based Compensation $55.72M $49.49M $41.12M $32.30M $34.24M $18.82M $6.96M $1.31M
Change in Receivables $986K $3.23M -$4.58M $11.76M -$11.63M -$596K -- --
Change in Payables -$10.25M $10.68M $5.78M -$17.12M $16.25M $1.25M $967K -$928K
Operating Cash Flow -$407.3M -$375.9M -$214.2M -$188.2M -$106.1M -$83.33M -$53.36M -$28.55M
Capital Expenditure -$8.0K -$759K -$360K -$197K -$254K -$210K -$31K -$52K
Free Cash Flow -$407.3M -$376.6M -$214.6M -$188.4M -$106.4M -$83.54M -$53.39M -$28.60M
Investing Cash Flow -$8.0K -$759K -$360K -$197K -$254K -$210K -$31K -$52K
Common Stock Issued $544.2M $450.0M $472.7M -- -- -- -- $14.91M
Financing Cash Flow $595.8M $454.5M $472.4M $70.89M $200.1M $383.1M $147.0M $35.58M
Net Change in Cash $188.1M $78.61M $258.8M -$117.3M $93.67M $299.6M $93.59M $6.99M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$97.25M -$153.2M -$147.9M -$110.6M -$126.5M -$120.6M -$106.4M -$111.1M
Depreciation & Amortization $89K $92K $96K $101K $105K $107K $109K $99K
Stock-Based Compensation $13.28M $13.77M $11.14M $12.71M $13.36M $18.51M $11.69M $11.65M
Change in Receivables $558K $436K $563K $319K -$25K $129K $85K -$197K
Change in Payables -$3.35M $2.60M -$1.35M $1.56M -$1.06M -$9.40M -$2.30M -$260K
Operating Cash Flow -$83.22M -$124.4M -$95.06M -$92.33M -$102.5M -$117.4M -$110.6M -$100.4M
Capital Expenditure -- -- -$8.0K $0 $0 $0 -$201K -$180K
Free Cash Flow -- -- -$95.07M -$92.33M -$102.5M -$117.4M -$110.8M -$100.6M
Investing Cash Flow -- -- -$8.0K $0 $0 $0 -$201K -$180K
Financing Cash Flow $7.88M $20.10M $3.64M $564.6M $24.59M $2.92M $450.6M $2.46M
Net Change in Cash -$75.52M -$104.3M -$92.42M $472.7M -$77.04M -$115.1M $339.3M -$98.26M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Return on Equity (ROE) -59.3% -58.5% -42.0% -58.2% -33.4% -27.4% -70.6% -389.7%
Return on Assets (ROA) -52.8% -53.3% -38.9% -52.0% -30.4% -26.0% -60.7% -206.8%
Current Ratio 9.09x 11.16x 13.70x 9.34x 11.52x 21.79x 7.12x 41.87x
Quick Ratio 8.65x 10.41x 13.18x 8.71x 11.37x 21.35x 6.57x 23.25x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.01x 0.01x -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -77.5% -73.2% -59.3% -47.1% -89.4% -73.5% -58.5% -108.5%
Return on Assets (ROA) -66.9% -63.1% -52.8% -44.1% -79.7% -67.6% -53.3% -90.9%
Current Ratio 7.31x 7.27x 9.09x 15.74x 9.07x 12.32x 11.16x 6.04x
Quick Ratio 6.94x 6.82x 8.65x 15.03x 8.28x 11.36x 10.41x 5.52x
Debt to Equity -- -- 0.00x -- -- -- 0.00x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001764013) · from June 30, 2018 Data through September 30, 2026 · synced Nov 20, 2026, 05:11 UTC · Open in terminal